Nanologica マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Andreas Bhagwani

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	13.8yrs
CEOの所有権	n/a
経営陣の平均在職期間	3.8yrs
取締役会の平均在任期間	5.3yrs

経営陣の近況

Recent updates

Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%

Feb 23

CEO報酬分析

Nanologica の収益と比較して、Andreas Bhagwani の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	n/a	n/a	-SEK 76m
Mar 31 2024	n/a	n/a	-SEK 80m
Dec 31 2023	n/a	n/a	-SEK 75m
Sep 30 2023	n/a	n/a	-SEK 53m
Jun 30 2023	n/a	n/a	-SEK 53m
Mar 31 2023	n/a	n/a	-SEK 51m
Dec 31 2022	SEK 3m	SEK 2m	-SEK 55m
Sep 30 2022	n/a	n/a	-SEK 56m
Jun 30 2022	n/a	n/a	-SEK 57m
Mar 31 2022	n/a	n/a	-SEK 53m
Dec 31 2021	SEK 2m	SEK 2m	-SEK 45m
Sep 30 2021	n/a	n/a	-SEK 35m
Jun 30 2021	n/a	n/a	-SEK 28m
Mar 31 2021	n/a	n/a	-SEK 23m
Dec 31 2020	SEK 2m	SEK 1m	-SEK 22m

報酬と市場: Andreasの総報酬がSwedish市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Andreasの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Andreas Bhagwani (49 yo)

13.8yrs

在職期間

SEK 2,818,341

報酬

Mr. Andreas Bhagwani has been Chief Executive Officer of Nanologica AB (publ) since 2011. Mr. Bhagwani is a Co-Founder of Sigrid Therapeutics AB (obesity therapy) and Atrogi AB (diabetes). He is also Co-Fo...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Andreas Bhagwani	Chief Executive Officer	13.8yrs	SEK 2.82m	データなし
Eva Osterman	Chief Financial Officer	7.8yrs	データなし	0.12% SEK 111.3k
Åsa Bergström	Chief Operating Officer	less than a year	データなし	データなし
Johanna Johansson	Director of IR	no data	データなし	データなし
P. Dutta	Senior VP of Sales & Senior Advisor of Chromatography	3.8yrs	データなし	データなし
Katarina Alenas	Senior Vice President of Chromatography	2.7yrs	データなし	データなし

3.8yrs

平均在職期間

53.5yo

平均年齢

経験豊富な経営陣: NICAの経営陣は経験豊富であると考えられます ( 3.8年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Lena Torlegard	Independent Director	10.8yrs	SEK 222.50k	0.017% SEK 16.6k
Thomas Eldered	Director	3.8yrs	SEK 202.50k	データなし
Gisela Sitbon	Independent Chairman of the Board	12.8yrs	SEK 320.00k	0.060% SEK 57.9k
Anders Rabbe	Independent Director	4.8yrs	SEK 195.00k	0.030% SEK 28.9k
Mattias Bengtsson	Independent Director	5.8yrs	SEK 195.00k	0.029% SEK 28.2k
Alexandra Montgomery	Director	less than a year	データなし	データなし

5.3yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: NICAの取締役会は経験豊富であると考えられます ( 5.3年の平均在任期間)。

Nanologica マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Nanologica AB (Publ) Elects Alexandra Blomberg Montgomery as New Member of the Board of Directors

Nanologica AB (publ) Announces Chief Operating Officer Changes

Insufficient new directors

Nanologica AB (publ), Annual General Meeting, May 16, 2024

Nanologica AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Chief Scientific Officer, Gary Pitcairn Will Leave Nanologica AB (publ)

Recent updates

New major risk - Market cap size

Nanologica AB (Publ) Elects Alexandra Blomberg Montgomery as New Member of the Board of Directors

New major risk - Share price stability

New major risk - Financial position

Second quarter 2024 earnings released: kr0.25 loss per share (vs kr0.41 loss in 2Q 2023)

New major risk - Financial position

First quarter 2024 earnings released: kr0.46 loss per share (vs kr0.34 loss in 1Q 2023)

Nanologica AB (publ) Announces Chief Operating Officer Changes

New minor risk - Shareholder dilution

Full year 2023 earnings released: kr2.08 loss per share (vs kr1.84 loss in FY 2022)

Price target decreased by 25% to kr12.00

Full year 2023 earnings released: kr2.08 loss per share (vs kr1.84 loss in FY 2022)

Nanologica AB (publ) to Report Q2, 2024 Results on Jul 05, 2024

Insufficient new directors

New minor risk - Share price stability

Nanologica AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 54.2 million.

New major risk - Financial position

Third quarter 2023 earnings released: kr0.32 loss per share (vs kr0.39 loss in 3Q 2022)

Nanologica AB (publ), Annual General Meeting, May 16, 2024

Nanologica AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Nanologica (STO:NICA) Is Making Moderate Use Of Debt

New minor risk - Financial position

Second quarter 2023 earnings released: kr0.41 loss per share (vs kr0.48 loss in 2Q 2022)

Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?

Chief Scientific Officer, Gary Pitcairn Will Leave Nanologica AB (publ)

First quarter 2023 earnings released: kr0.34 loss per share (vs kr0.56 loss in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

No longer forecast to breakeven

Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Nanologica (STO:NICA) Is Making Moderate Use Of Debt

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr16.50

No longer forecast to breakeven

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Is Nanologica (NGM:NICA) A Risky Investment?

No longer forecast to breakeven

Third quarter 2021 earnings released: kr0.45 loss per share (vs kr0.32 loss in 3Q 2020)

Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?

First quarter 2021 earnings released: kr0.28 loss per share (vs kr0.40 loss in 1Q 2020)

Full year 2020 earnings released: kr0.80 loss per share (vs kr1.18 loss in FY 2019)

Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%

Nanologica Recruits PK Dutta as SVP Sales and Senior Advisor for Chromatography

New 90-day high: kr15.30

Nanologica AB (publ) Signs Collaboration Agreement with Zentiva for the Use of Nlab Drug Delivery Platforms

New 90-day high: kr13.80

Nanologica AB Engages Scientific Advisors Within Inhalation

Nanologica AB (Publ) Delivers Test Material from Large Scale Production

Nanologica AB (publ) to Report Q3, 2020 Results on Oct 30, 2020

New 90-day high: kr15.05

First half earnings released

New 90-day high - kr14.00

Nanologica AB (publ) to Report Q2, 2020 Results on Aug 21, 2020

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24